The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sarafidis, P. A., Lazaridis A. A., Ruiz-Hurtado G., & Ruilope L. M. (2017).  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.. Nat Rev Endocrinol. 13(6), 365-374.
Sarafidis, P. A., & Tsapas A. (2016).  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.. N Engl J Med. 374(11), 1092.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2019).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 34(3), 515-523.
Sarafidis, P. A., & Bakris G. L. (2014).  Early patterns of blood pressure change and future coronary atherosclerosis.. JAMA. 311(5), 471-2.
Sarafidis, P. A., Memmos E., Alexandrou M-E., & Papagianni A. (2018).  Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives.. Curr Pharm Des. 24(46), 5528-5536.
Sarafidis, P. A., & Ruilope L. M. (2013).  Renin-angiotensin-aldosterone system blockade in hypertensive patients with chronic kidney disease.. Blood Press. 22(6), 397-8.
Sarafidis, P. A., Georgianos P. I., & Lasaridis A. N. (2010).  Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy.. Expert Opin Drug Saf. 9(2), 259-73.
Sarafidis, P., & Papagianni A. (2019).  Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.. Ann Intern Med. 171(12), 943-944.
Sarafidis, K., Soubasi-Griva V., Piretzi K., Thomaidou A., Agakidou E., Taparkou A., et al. (2010).  Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates.. Intensive Care Med. 36(5), 864-8.
Sarafidis, K., Tsepkentzi E., Diamanti E., Agakidou E., Taparkou A., Soubasi V., et al. (2014).  Urine neutrophil gelatinase-associated lipocalin to predict acute kidney injury in preterm neonates. A pilot study.. Pediatr Nephrol. 29(2), 305-10.
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Sarafidis, P., & Bakris G. (2020).  Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?. Diabetes Care. 43(8), 1684-1686.
Sarafidis, P. A., & Lasaridis A. N. (2010).  Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy.. Nat Rev Nephrol. 6(8), 447-9.
Sarafidis, K., Begou O., Deda O., Gika H., Agakidis C., Efstathiou N., et al. (2019).  Targeted urine metabolomics in preterm neonates with intraventricular hemorrhage.. J Chromatogr B Analyt Technol Biomed Life Sci. 1104, 240-248.
Sarafidis, P. A. (2011).  Epidemiology of resistant hypertension.. J Clin Hypertens (Greenwich). 13(7), 523-8.
Sarafidis, P. A. (2017).  Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?. Am J Nephrol. 46(4), 285-287.
Sarafidis, P. A., Kamperidis V., Loutradis C., Tsilonis K., Mpoutsiouki F., Saratzis A., et al. (2017).  Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes?. Nephrol Dial Transplant. 32(8), 1402-1409.
Sarafidis, K., Stathopoulou T., Agakidou E., Taparkou A., Soubasi V., Diamanti E., et al. (2011).  Comparable effect of conventional ventilation versus early high-frequency oscillation on serum CC16 and IL-6 levels in preterm neonates.. J Perinatol. 31(2), 104-11.
Sarafidis, P. A., & Ruilope L. M. (2013).  Blood pressure targets for patients with chronic kidney disease.. Blood Press. 22(6), 395-6.
Sarafidis, K., Iosifidis E., Gikas E., Tsivitanidou M., Drossou-Agakidou V., & Roilides E. (2010).  Daptomycin use in a neonate: serum level monitoring and outcome.. Am J Perinatol. 27(5), 421-4.
Sarafidis, P. A., & Ortiz A. (2020).  The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?. Clin Kidney J. 13(1), 24-26.
Sarafidis, P., Loutradis C., Ferro C. J., & Ortiz A. (2020).  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?. Am J Nephrol. 51(7), 553-555.
Sarafidis, P. A., Georgianos P. I., Germanidis G., Giavroglou C., Nikolaidis P., Lasaridis A. N., et al. (2012).  Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.. Am J Kidney Dis. 59(3), 434-8.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2018).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 33(10), 1872.
Sarafidis, P., Loutradis C., Ortiz A., & Ruilope L. M. (2020).  Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT.. Clin Kidney J. 13(3), 287-290.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.